Inventor · disambiguated record
Xiaolin Hao
Also filed as: HAO XIAOLIN
28 granted patents·15 pending applications·251 citations·filing 2001–2022
96Inventor score
Files withAMGEN INC18CHEN YI8NANJING ZHENGXIANG PHARMACEUTICALS CO LTD7NANJING ZENSHINE PHARMACEUTICALS CO LTD3CUSHING TIMOTHY DAVID2
Top patents by PatentIndex Score
43 records- 0196US7705018B2Substituted quinolines and their uses in treatment of inflammatory and related conditionsAMGEN INC·Filed 2008·Granted Apr 27, 2010·51 cites·10 claims
- 0293US7199119B2Antiinflammation agentsAMGEN INC·Filed 2003·Granted Apr 3, 2007·75 cites·11 claims
- 0391US8586739B2Heterocyclic compounds and their usesCHEN YI·Filed 2012·Granted Nov 19, 2013·13 cites·7 claims
- 0491US8193199B2Heterocyclic compounds and their usesCHEN YI·Filed 2008·Granted Jun 5, 2012·15 cites·15 claims
- 0590US7919498B2Substituted pyrazolo[3,4-d]pyrimidines as PI3K inhibitorsAMGEN INC·Filed 2008·Granted Apr 5, 2011·16 cites·7 claims
- 0686US7635695B2Antiinflammation agentsAMGEN INC·Filed 2007·Granted Dec 22, 2009·10 cites·20 claims
- 0783US7244727B2Fused bicyclic nitrogen-containing heterocyclesJAPAN TOBACCO INC·Filed 2003·Granted Jul 17, 2007·22 cites·57 claims
- 0882US8716290B2Heterocyclic compounds and their usesAMGEN INC·Filed 2013·Granted May 6, 2014·5 cites·15 claims
- 0981US6846834B2Antiinflammation agentsAMGEN INC·Filed 2001·Granted Jan 25, 2005·15 cites·73 claims
- 1080US8901135B2Heterocyclic compounds and their usesCHEN YI·Filed 2012·Granted Dec 2, 2014·3 cites·16 claims
- 1179US8633313B2Heterocyclic compounds and their usesCUSHING TIMOTHY DAVID·Filed 2010·Granted Jan 21, 2014·5 cites·8 claims
- 1279US8329910B2Quinolines for the treatment of PI3K-δ mediated diseasesCHEN YI·Filed 2011·Granted Dec 11, 2012·3 cites·10 claims
- 1379US7186841B2Antiinflammation agentsSYNTEX LLC·Filed 2004·Granted Mar 6, 2007·11 cites·4 claims
- 1477US8754089B2Heterocyclic compounds and their usesCUSHING TIMOTHY DAVID·Filed 2010·Granted Jun 17, 2014·4 cites·3 claims
- 1573US9873701B2Heterocyclic compounds and their usesAMGEN INC·Filed 2014·Granted Jan 23, 2018·1 cites·16 claims
- 1672US9365522B2Pyrazole amide derivativeAMGEN INC·Filed 2015·Granted Jun 14, 2016·2 cites·14 claims
- 1768US11542262B2Phosphatidylinositol 3-kinase inhibitorsNANJING ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2022·Granted Jan 3, 2023·0 cites·26 claims
- 1867US11673889B2Substituted imidazo[4,5-c][1,8]naphthyridines as phosphodiesterase inhibitorsNANJING ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2022·Granted Jun 13, 2023·0 cites·17 claims
- 1967US2020048265A1Heterocyclic compounds and their usesAMGEN INC·Filed 2019·Application pending·0 cites
- 2064US11446301B2Quinoline analogs as phosphatidylinositol 3-kinase inhibitorsNANJING ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2020·Granted Sep 20, 2022·0 cites·20 claims
- 2163US2018105532A1Heterocyclic compounds and their usesAMGEN INC·Filed 2017·Application pending·0 cites
- 2261US11466029B2Compounds useful to treat influenza virus infectionsNANJING ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2022·Granted Oct 11, 2022·0 cites·18 claims
- 2361US2024182407A1Quinoline compound salt or crystal form, preparation method therefor, and application thereofNANJING ZENSHINE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2460US2023014730A1Phosphodiesterase inhibitors and useNANJING ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 2558US8183259B2Heterocyclic compounds and their usesCHEN YI·Filed 2011·Granted May 22, 2012·0 cites·8 claims
- 2658US2023227446A9Phosphatidylinositol 3-kinase inhibitorsNANJING ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 2757US8183258B2Heterocyclic compounds and their usesCHEN YI·Filed 2011·Granted May 22, 2012·0 cites·10 claims
- 2857US2007135464A1Antiinflammation agentsAMGEN INC·Filed 2007·Application pending·0 cites
- 2956US2023271943A1Compounds as dhodh inhibitorsNANJING ZENSHINE PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3054US10792283B2Quinoline analogs as phosphatidylinositol 3-kinase inhibitorsHANGZHOU ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2017·Granted Oct 6, 2020·0 cites·20 claims
- 3153US8835432B2Heterocyclic compounds and their usesAMGEN INC·Filed 2014·Granted Sep 16, 2014·0 cites·8 claims
- 3253US2022033416A1Compounds useful to treat influenza virus infectionsNANJING ZHENGXIANG PHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 3352US2007244096A1Fused Bicyclic Nitrogen-Containing HeterocyclesJAPAN TOBACCO INC·Filed 2007·Application pending·0 cites
- 3452US2010179177A1Heterocyclic compounds and their usesAMGEN INC·Filed 2010·Application pending·0 cites
- 3550US2025136568A1Fused heterocyclic compounds as pi3kalpha inhibitorsNANJING ZENSHINE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 3647US8022061B2N-aryl pyrazole compounds, compositions, and methods for their useAMGEN INC·Filed 2007·Granted Sep 20, 2011·0 cites·15 claims
- 3746US9873704B2Heterocyclic compounds and their usesAMGEN INC·Filed 2016·Granted Jan 23, 2018·0 cites·3 claims
- 3845US2011152277A1Heterocyclic compounds and their usesCHEN YI·Filed 2011·Application pending·0 cites
- 3943US7763624B2Substituted pyrazolo[3,4-d]pyrimidines as ACK-1 and LCK inhibitorsAMGEN INC·Filed 2006·Granted Jul 27, 2010·0 cites·34 claims
- 4043US2010331306A1Heterocyclic compounds and their usesAMGEN INC·Filed 2010·Application pending·0 cites
- 4140US7176314B2Inflammation modulatorsAMGEN INC·Filed 2002·Granted Feb 13, 2007·0 cites·45 claims
- 4239US2013267526A1Heterocyclic compounds and their usesCHEN YI·Filed 2011·Application pending·0 cites
- 4335US2013085131A1Heterocyclic compounds and their usesBUI MINNA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaolin Hao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →